Serious illness after stem cell transplant
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at patients who had a stem cell transplant and later became critically ill, needing care in the intensive care unit (ICU). The goal is to learn more about what happens during these serious illnesses and how to improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stem cell transplant (hematopoietic cell transplantation).
- You are now in the intensive care unit (ICU) for a serious illness related to your transplant.
- Your ICU stay is not just for routine monitoring after surgery and lasts more than 2 days.
- Your medical team has all the key information needed about your time in the ICU.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients who have had a stem cell transplant to see how their heart and blood vessels are doing over time. It helps doctors learn about long-term heart risks after transplant.
This study looks at how your immune system and inflammation affect your recovery in the intensive care unit. Researchers want to understand why some patients do better than others.
This study focuses on critically ill people in the intensive care unit (ICU). It aims to learn what affects outcomes and resources, which may help improve how care is planned for ICU patients.
This study looks at patients who are in the Intensive Care Unit (ICU) after having surgery at this hospital. Researchers want to understand how general surgery patients do while in the ICU.
This study uses a special score (immune risk score) to check how well your immune system rebuilds after a half-matched stem cell transplant. The goal is to find patients who might need extra help with immune recovery.
This study looks at how often liver problems happen and how they develop in people being evaluated for a stem cell transplant. It may help doctors predict and better manage liver complications during and after transplant care.
Hear when a new Critical Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.